Ali is an epidemiologist and has worked in HIV since 1995 and with the MRC Clinical Trials Unit since 2005. She leads a programme of work on the epidemiology of HIV in children and young people in the UK and Europe. She gained an MSc and a PhD in Epidemiology at the London School of Hygiene and Tropical Medicine.
She leads the Collaborative HIV Paediatric Study (CHIPS), which is a cohort of HIV-infected children in the UK and Ireland, and she is establishing the long-term follow-up of this cohort in adulthood through the UK Register of HIV Seroconverters. She is the Principal Investigator for the Adolescents and Adults Living with Perinatal HIV (AALPHI) cohort of perinatally-HIV infected young people and a comparison group of HIV-negative controls. She co-coordinates the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC), which is part of the Paediatric European Network for the Treatment of AIDS (PENTA). CHIPS, AALPHI and EPPICC are all part of a large Network of Excellence, EuroCoord, and she leads a working group within EuroCoord on “kids to adults”.
Fish R, Judd A, Jungmann E, O’Leary C, Foster C. Mortality in perinatally HIV-infected young people in England following transition to adult care: an HIV Young Persons Network (HYPNet) audit. HIV Medicine 2014; 15(4): 239-244.
The European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord. Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants. AIDS 2013; 27(6): 991-1000.
The European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord. Early antiretroviral therapy in HIV-1 infected infants, 1996-2008: treatment response and duration of first-line regimens. AIDS 2011; 25(18): 2279-2287.
Pursuing Later Treatment Options II (PLATO II) project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE). Risk of triple-class virological failure in children with HIV: a retrospective cohort study. Lancet 2011; 377(9777): 1580-1587.
Judd A, Boyd KL, Stöhr W, Dunn D, Butler K, Lyall H, Sharland M, Shingadia D, Riordan A, Gibb DM. Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case-control study. AIDS 2010; 24(4):525-34.